Chronic Disease Management Market Size & Share, by Type (Solutions, Services); Deployment Mode (On-Premise, Web-Based, Cloud-Based); Disease Type (Cancer, Diabetes, Cardiovascular Diseases, Arthritis, Asthma, Chronic Obstructive Pulmonary Disorders (COPD); Stroke); Service Type (Consulting Service, Implementation Service, Educational Services); End-user (Providers, Payers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4242
  • Published Date: Aug 22, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023 - 2035

Chronic Disease Management Market size is poised to cross USD 27 Billion by the end of 2035, growing at a CAGR of 13% during the forecast period, i.e., 2023 – 2035. In the year 2022, the industry size of chronic disease management was USD 6 Billion. The reason behind the growth is impelled by the increasing use of tobacco across the globe which has led to an increase in the prevalence of various types of chronic diseases, which is increasing the death rate and the need for long-term intensive care.

For instance, the tobacco epidemic, which kills more than 6 million people a year worldwide, is known to be one of the greatest risks to public health the world has ever seen.

The worldwide upsurge in chronic obstructive pulmonary disease (COPD) across the world is believed to fuel the chronic disease management market. Chronic obstructive pulmonary disease (COPD) is a long-term disease that occurs when the lungs and air route become damaged. The upsurge in COPD is also leading to an increase in demand for chronic disease management. As per the data provided by the World Health Organization, globally, 3.23 million people died from chronic obstructive pulmonary disease (COPD) in 2019.


Chronic Disease Management Market
Get more information on this report: Request Free Sample PDF


Chronic Disease Management Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~13%

Base Year Market Size (2022)

~ USD 6 Billion

Forecast Year Market Size (2035)

~ USD 27 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Chronic Disease Management Market: Growth Drivers and Challenges

Market-Growth-Drivers

Growth Drivers

  • Increasing Geriatric Population with Decreased Immunity– Despite weak immune systems aging brings several other health issues that require intensive care and health monitoring of old people. So, an increase in the geriatric population is fueling the demand for chronic disease management. According to the data provided by the World Health Organization (WHO), the population of people aged 60 and up has increased from 1 billion in 2020 to 1.4 billion around the globe.
  • Rise in Musculoskeletal Diseases - A collection of illnesses known together as musculoskeletal disorders affect the bones, tendons, muscles, cartilage, and other components of the musculoskeletal system. For instance, back discomfort, osteoarthritis, rheumatoid arthritis, and osteoporosis are among these disorders. Furthermore, if osteoarthritis treatment is not provided effectively, can lead to major health issues. In addition, musculoskeletal ailments are the main cause of disability worldwide. For instance, worldwide, 1.71 billion people have been suffering from musculoskeletal conditions.

Challenges

  • High-Cost Associated with Chronic Diseases Treatment- Chronic diseases are long-term illnesses that need treatment for a lifetime in many cases, such as diabetes. The medications and therapy procedures for chronic diseases are very expensive such as chemotherapy in the case of cancer. HIV and AIDS also include in this category, hampering the growth of the market.
  • High Initial Investments
  • Lack of Trained Workforce with Cross-Functional Skills


Chronic Disease Management Segmentation

Disease Type (Cancer, Diabetes, Cardiovascular Diseases, Arthritis, Asthma, Chronic Obstructive Pulmonary Disorders (COPD), Stroke)

The cardiovascular diseases segment is estimated hold 30% share of the global chronic disease management market in the coming years owing to the growing prevalence of chronic illnesses in the world. Moreover, heart failure, coronary artery disease, stroke, and other illnesses that impact the blood vessels and the heart are all included in CVD. Blood pressure, high blood cholesterol, smoking, inactivity, a poor diet, and obesity are all CVD risk factors. A major amount of the global illness burden is attributable to CVD, which is one of the main causes of mortality worldwide.

According to the World Health Organization (WHO), the largest cause of mortality worldwide is cardiovascular disease (CVD), followed by cancer, respiratory conditions, and diabetes. Furthermore, more than 17 million people die every year owing to cardiovascular diseases around the world.

Type (Solutions, Services)

Chronic disease management market from the solutions segment is set to garner a notable share shortly on the back of increased awareness regarding the use of cloud-based healthcare solutions. The best option to enable patients to share health information for advancing the treatment of chronic diseases is determined to be a hybrid cloud solution as it enhances the environment for healthcare, enables remote monitoring, boosts operational effectiveness, and reduces costs. This can help in the management of chronic diseases more efficiently.

Our in-depth analysis of the global chronic disease management market includes the following segments:

   Type

  • Solutions
  • Services

   Deployment Mode

  • On-Premise
  •  Web-Based
  •  Cloud-Based

   Disease Type

  • Cancer, Diabetes
  •  Cardiovascular Diseases
  •  Arthritis
  •  Asthma
  •  Chronic Obstructive Pulmonary Disorders (COPD)
  • Stroke

   Service Type

  • Consulting Service
  •  Implementation Service
  • Educational Services

   End-User

  • Providers
  •  Payers

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Chronic Disease Management Industry- Regional Synopsis

North American Market Forecast

Chronic Disease Management market in North America is predicted to account for the largest share of 47% by 2035 impelled by increasing spending in healthcare. This has led to an increase in access to quality medical treatments for people with chronic diseases in the region. Besides this, owing to the availability of sufficient resources more specialized training is being given to the medical professionals in the region for managing chronic conditions. In 2021, the United States spent over 2% more on health care, amounting to roughly USD 4 trillion or around USD 12,910 per person.

European Market Statistics

The Europe chronic disease management market is estimated to hold the second largest of 29%, during the forecast timeframe led by growing awareness regarding health. As a result, more people in the region can access medical care for the timely management and diagnosis of several chronic conditions.

Research Nester
Chronic Disease Management Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Chronic Disease Management Market

top-features-companies
    • WellSky Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Cedar Gate Technologies
    • Pegasystems Inc.
    • Koninklijke Philips N.V
    • Altruista Health
    • Cognizant TriZetto Software Group Inc
    • Infosys Limited
    • Hinduja Global Solutions Ltd.
    • Epic Systems Corporation
    • NXGN Management

In-the-news

In The News

  • WellSky Corporation launched new predictive analytics capabilities that will make it easier for hospitals, payers, and post-acute care providers to recognize patients who need hospice care and will enable more than 10 million hospital discharges annually.
  • Biofourmis Inc. introduced a chronic condition-management service dubbed Biofourmis Care that focuses on managing lipids, atrial fibrillation, diabetes, hypertension, and heart failure, and will further enable it to provide care for every stage of the care continuum, and remote monitoring for patients after discharge.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4242
  • Published Date: Aug 22, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing use of tobacco across the globe and the worldwide upsurge in chronic obstructive pulmonary disease (COPD) are the major factors driving the growth of the market.

The market size of Chronic Disease Management is anticipated to attain a CAGR of 13% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Cedar Gate Technologies, Pegasystems Inc., Koninklijke Philips N.V, Altruista Health, Cognizant TriZetto Software Group Inc, Infosys Limited, Hinduja Global Solutions Ltd., Epic Systems Corporation.

The cardiovascular diseases segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Chronic Disease Management Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying